Showing results (381-390 of 528) with videos related to
Sort By:
Pageof 53
Alimentary Pharmacology & Therapeutics|April 29, 2004
Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States populationG R Locke, B P Yawn, P C Wollan, et al.Gut|May 15, 2008
Prevalence and risk factors for abdominal bloating and visible distention: a population-based studyX Jiang, G R Locke, R S Choung, et al.Gastroenterology|August 1, 1990
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndromeN J Talley, S F Phillips, B Bruce, et al.Alimentary Pharmacology & Therapeutics|July 10, 2003
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom IndexD A Revicki, A M Rentz, D Dubois, et al.Neurogastroenterology and Motility|August 5, 2005
Aerophagia in children: characterization of a functional gastrointestinal disorderD K Chitkara, A J Bredenoord, A J Bredenood, et al.Neurogastroenterology and Motility|December 4, 2003
The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimatesY A Saito, N J Talley, L J Melton, et al.Gut|August 24, 1999
Functional gastroduodenal disordersN J Talley, V Stanghellini, R C Heading, et al.Alimentary Pharmacology & Therapeutics|March 30, 2011
Functional dyspepsia impairs quality of life in the adult populationP Aro, N J Talley, L Agréus, et al.Alimentary Pharmacology & Therapeutics|December 8, 2007
Mortality rates in patients with Barrett's oesophagusP Moayyedi, N Burch, N Akhtar-Danesh, et al.Alimentary Pharmacology & Therapeutics|December 17, 2008
Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort studyM A McNally, G R Locke, A R Zinsmeister, et al.Pageof 53